Health · 28 Oct
Hepatitis B | హెపటైటిస్ బి వ్యాధిగ్రస్తులకు కొత్త ఔషధం.. ఆమోదం తెలిపిన అమెరికా ఎఫ్డీఏ..
AI summaryThe US Food and Drug Administration (FDA) approved a new gene-targeting injection called Hep-B-Sago (bepirovirsen) for treating chronic Hepatitis B in adults. The medication allows select patients to discontinue antiviral drugs while keeping the virus under control, though it carries risks such as severe liver problems and bleeding.
1 outlet